Mutant EGFR inhibitor

CAS : 1421373-62-7

Ref. 3D-WGC37362

Informations sur le produit

• Nom: Mutant EGFR inhibitor
• Marque: Biosynth
• Description: Mutant EGFR inhibitor is a targeted therapeutic agent, which is a pharmaceutical compound originating from advanced drug discovery platforms. Its mode of action involves the selective inhibition of epidermal growth factor receptor (EGFR) proteins that carry specific mutations, such as L858R or exon 19 deletions, often implicated in tumorigenesis. By binding to the ATP-binding site of the mutant EGFR, this inhibitor prevents the phosphorylation cascade necessary for downstream signaling, effectively blocking pathways involved in cell proliferation and survival.

Propriétés chimiques

• Masse moléculaire: 520.03 g/mol
• Formule: C₂₇H₃₀ClN₇O₂
• Degré de pureté: Min. 95%